Nancy Simonian
Vermögen: 1 $ am 31.05.2026
Vermögen: 1 $ am 31.05.2026
Nancy A. Simonian was the founder of Syros Pharmaceuticals, Inc., founded in 2011, where the titles held included President, Chief Executive Officer & Director from 2021 to 2025.
Current jobs include Director at Biotechnology Innovation Organization since 2015, Director at The Damon Runyon Cancer Research Foundation since 2014, Non-Executive Director at Generate Biomedicines, Inc. since 2024, Director at Alltrna, and Member-Supervisory Board at Bayer AG since 2024.
Former jobs include Senior Director-Medical Research at Biogen, Inc. from 2000 to 2001, Director at ArQule, Inc. from 2006 to 2011, Independent Director at Seagen, Inc. from 2012 to 2023, Director at Personalized Medicine Coalition, Independent Director at Evelo Biosciences, Inc. from 2018 to 2021, Faculty Member at The General Hospital Corp., Assistant Professor at The Massachusetts General Hospital from 1992 to 1997, Chief Medical Officer at Millennium Pharmaceuticals, Inc. from 2006 to 2011, and Assistant Professor at Harvard Medical School from 1992 to 1994.
Education includes an undergraduate degree from Princeton University conferred in 1983, a doctorate from Perelman School of Medicine conferred in 1988, and a doctorate from the University of Pennsylvania Medical Center.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.12.2024 | 4.000 ( 0,01 % ) | 1 $ | 31.05.2026 | |
| 27.02.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BAYER AG | Direktor/Vorstandsmitglied | 26.04.2024 |
| GENERATE BIOMEDICINES, INC. | Direktor/Vorstandsmitglied | 01.06.2024 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | 06.07.2015 |
Alltrna
Alltrna Pharmaceuticals: MajorHealth Technology Develops tRNA-based medicines for genetic disorders | Direktor/Vorstandsmitglied | - |
The Damon Runyon Cancer Research Foundation
The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services Supports cancer research | Direktor/Vorstandsmitglied | 01.10.2014 |
| Unternehmen | Position | Ende |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 28.02.2025 |
| SEAGEN INC. | Direktor/Vorstandsmitglied | 14.12.2023 |
| EVELO BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 10.06.2021 |
| ARQULE, INC. | Direktor/Vorstandsmitglied | 31.03.2011 |
| ░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 18 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
ArQule, Inc.
ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Bayer AG
Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Damon Runyon Cancer Research Foundation
The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services Supports cancer research | Commercial Services |
The Massachusetts General Hospital
The Massachusetts General Hospital Hospital/Nursing ManagementHealth Services Operates as a cancer care hospital | Health Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Personalized Medicine Coalition
Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services Engages in promoting the understanding and adoption of personalized medicine concepts, services and products | Commercial Services |
Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Perelman School of Medicine
Perelman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania Medical Center
University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evelo Biosciences, Inc.
Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases | Health Technology |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Operates as a clinical-stage generative biology company that provides biotechnology and drug design & development services | Health Technology |
Alltrna
Alltrna Pharmaceuticals: MajorHealth Technology Develops tRNA-based medicines for genetic disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen